Education
About Us
Working with TipRanks
Follow Us
Clinical Laserthermia Systems AB Class B (SE:CLS.B)
:CLS.B
RESEARCH TOOLSreports
CLS.B Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr2.43 - kr22.63
Previous CloseN/A
Volume24.29K
Average Volume (3M)71.98K
Market Cap
kr58.48M
Enterprise Valuekr48.49M
Total Cash (Recent Filing)kr15.33M
Total Debt (Recent Filing)kr454.00K
Price to Earnings (P/E)―
Beta1.35
Next Earnings
May 16, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.06
Shares Outstanding20,163,593
10 Day Avg. Volume80,943
30 Day Avg. Volume71,980
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
CLS.B FAQ
What was Clinical Laserthermia Systems AB Class B’s price range in the past 12 months?
Clinical Laserthermia Systems AB Class B lowest stock price was kr2.43 and its highest was kr22.63 in the past 12 months.
What is Clinical Laserthermia Systems AB Class B’s market cap?
Clinical Laserthermia Systems AB Class B’s market cap is kr58.48M.
When is Clinical Laserthermia Systems AB Class B’s upcoming earnings report date?
Clinical Laserthermia Systems AB Class B’s upcoming earnings report date is May 16, 2025 which is in 5 days.
How were Clinical Laserthermia Systems AB Class B’s earnings last quarter?
Clinical Laserthermia Systems AB Class B released its earnings results on Feb 21, 2025. The company reported -kr0.43 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.43.
Is Clinical Laserthermia Systems AB Class B overvalued?
According to Wall Street analysts Clinical Laserthermia Systems AB Class B’s price is currently Overvalued.
Does Clinical Laserthermia Systems AB Class B pay dividends?
Clinical Laserthermia Systems AB Class B does not currently pay dividends.
What is Clinical Laserthermia Systems AB Class B’s EPS estimate?
Clinical Laserthermia Systems AB Class B’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Clinical Laserthermia Systems AB Class B have?
Clinical Laserthermia Systems AB Class B has 20,163,593 shares outstanding.
What happened to Clinical Laserthermia Systems AB Class B’s price movement after its last earnings report?
Clinical Laserthermia Systems AB Class B reported an EPS of -kr0.43 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.618%.
Which hedge fund is a major shareholder of Clinical Laserthermia Systems AB Class B?
Currently, no hedge funds are holding shares in SE:CLS.B
---
Company Description
Clinical Laserthermia Systems AB Class B
Clinical Laserthermia Systems AB Class B (CLS.B) is a Swedish company specializing in the development and commercialization of advanced laser-based medical technologies. The company's core focus is on delivering innovative thermal treatment solutions for cancer care. Its flagship product, TRANBERG® Thermal Therapy System, is designed to provide precision thermal ablation therapies, which can be used in conjunction with other cancer treatments such as immunotherapy. CLS.B operates primarily in the medical devices and healthcare sectors, aiming to improve patient outcomes through minimally invasive procedures.
---
Technical Analysis
---